OB/GYN faculty, fellows, and residents at SLR have given birth in the last 2 months to a variety of scholarly publications, reviewing the role of minimally-invasive surgery in ovarian cancer, investigating factors that predict IVF success or failure, optimizing methods of pre-implantation embryo biopsy and genetic screening during IVF, comparison-testing methods for labor induction, and characterizing fetal uterine development.
Sept 25, 2012 - In an interview on Channel 4's New York Live, Urogynecologist Lisa Dabney, MD, debunks several myths about urinary incontinence.
High Risk Pregnancy and Age
In a recent video interview (below), Lois Brustman, MD, explains that women of any age can be at risk for pregnancy complications. Dr. Brustman is a maternal-fetal medicine specialist at Roosevelt Hospital.
Pregnancy Care is a Global Human Rights Issue
This was the message at a special SLR OB/GYN Department Grand Rounds presentation and discussion on January 10. The morning began with a screening of the documentary film “No Woman, No Cry,” which explores severe, widespread obstacles to good maternal-child health care around the world. Afterwards, SLR Gynecology Director Jacques Moritz, MD, gave a presentation, “Maternal Mortality: New York City and the World,” focused on local and national increases in maternal mortality over the last 25 years, the risk factors, and the solutions that need to be put in place. He was then joined by film producer and director Christy Turlington Burns, with whom he led a productive and inspiring dialogue with the clinical staff of the department. Click here for more on the film and the discussion.
Left to right, Turlington-Burns and faculty physicians Uchenna Acholonu Jr, MD, and Samantha Feder, MD.
Robotically-Assisted Laparoscopic Radical Hysterectomy and Lymphadenectomy
This is a minimally-invasive surgical treatment for cervical cancer. In the following video of the procedure, Farr Nezhat, MD, will remove the lymph nodes, uterus, parametrium, and cervix. Dr. Nezhat is Director of Minimally-Invasive Surgery and Gynecologic Robotics.
FDA Reports to Patients on Risks of Vaginal Mesh
March 27, 2013
The FDA wants patients with pelvic-organ prolapse to know that having a surgery with transvaginal mesh may put you at risk for needing additional surgery, and in some cases, repeat surgery may not resolve complications. Click here for the full patient advisory PDF.
Controversies in the Field of Urogynecology: Mesh Used in Vaginal Surgery
Message from the Urogynecology Division, Department of Obstetrics and Gynecology, St. Luke’s and Roosevelt Hospitals
An ongoing public controversy was stimulated by the FDA’s 2011 warning regarding the use of synthetic mesh in vaginal surgery for prolapse.
As a matter of fact, departmental urogynecologists Lisa Dabney, MD, and Anne Hardart, MD, have never used much mesh in their practices. They have been especially reluctant to use mesh to augment pelvic-organ-prolapse repairs performed through the vaginal route. Fortunately, they have extensive expertise in performing these procedures vaginally without the use of mesh—and they have had excellent results. Read full story here.
The Least-Invasive Route for Gynecologic Surgery is Through the Vagina
AN EXPERT’S VIEWPOINT:
There has been a lot of talk in the media about minimally-invasive surgery for uterine fibroids, endometriosis, and other noncancerous gynecologic problems. The route discussed for these surgeries is usually laparoscopic; that is, through small incisions in the abdomen for insertion of a camera and instruments. While this approach has revolutionized some procedures, especially those for cancer cases, sometimes the practice of laparoscopy overshadows the least invasive approach for noncancerous gynecological conditions: the vaginal approach. Read full story here
Minimal Stimulation IVF
The Continuum Reproductive Center is among a limited number of fertility practices now offering minimal-stimulation in vitro fertilization (MS-IVF). MS-IVF is a less invasive IVF protocol than conventional IVF and is an appropriate alternative for certain patient groups. The Continuum Reproductive Center’s medical and scientific team is highly respected in the field of reproductive medicine, and has expertise and many years of experience in all aspects and types of IVF.
Welcome to the Department of Obstetrics and Gynecology at St. Luke's-Roosevelt Hospital Center
The department is dedicated to the finest and most comprehensive women's reproductive health care and perinatal care. St. Luke’s-Roosevelt Hospital Center is an academic affiliate of Columbia University College of Physicians and Surgeons, and we are committed to the teaching and training of fully-qualified, well-rounded obstetricians and gynecologists. In addition, we are committed to furthering research into the most promising therapies in the field.
This website is designed to provide you with information about our clinical, residency and research programs, and our physicians and other clinical staff, whether you are seeking medical care, considering a residency in obstetrics and gynecology, or pursuing research. Also, an overall view of departmental leadership is described under Administration on the main navigation bar.
Our department includes a large group of general obstetrician-gynecologists, each trained to provide comprehensive care for a woman's overall health. Highly-trained midwives are also available for normal obstetric and gynecologic care. In addition, we have groups of specialists in seven major divisions that together encompass a woman's total reproductive health at all stages of her life, including the full range of obstetric needs and early infant care.
On this website, you can find out about these providers and programs. From the main navigation bar on the left side of every page, you can visit the Clinical Services section to develop an understanding of the various clinical programs we offer, as well as their physicians and other clinical staff. As an alternative, you can go to Find A Provider and begin by browsing information about our physicians, specialists, genetic counselors, and midwives.
If you are interested in having a baby at St. Luke's-Roosevelt Hospital Center, go to Clinical Services on the main navigation bar, and choose Giving Birth With Us. Roosevelt has Manhattan's first in-hospital Birthing Center, located only a floor away from our complete, state-of-the-art Labor and Delivery Suite. These unique facilities allow us to offer many options along with great flexibility and safety in the birthing process. We can help you from the time you begin planning you pregnancy until you and your baby arrive at home.
When you decide you would like to give birth at St. Luke's-Roosevelt, the first step is to choose a general obstetrician or midwife for a normal pregnancy, as described above. Alternatively, our Division of Maternal-Fetal has several physicians who are expert in supporting women with complicated pregnancies.
Whether you have a doctor at St. Luke's-Roosevelt or not, our genetics and ultrasound sections can provide state-of-the-art screening and diagnostic services. The Genetics Division offers complete prenatal testing and counseling services. The Ultrasound and Evaluation Center diagnoses all maternal, fetal and gynecologic problems using the latest technology.
At the new Continuum Reproductive Center, our Reproductive Endocrinology and Infertility Division provides comprehensive treatment for infertility, including in vitro fertilization. They also treat recurrent pregnancy loss and hormonally related health problems. The Gynecologic Oncology Division provides an advanced and complete program for women with gynecologic cancers. Our Urogynecology Division offers a wide range of treatment and education options for bladder control problems, including all the latest nonsurgical options.
Department Chairman Peter McGovern, MD
In Top 1% of Infertility Specialists Nationwide
As Ranked by Castle-Connelly
Peter. G. McGovern, MD, Chairman of the Department of Obstetrics and Gynecology at St. Luke’s and Roosevelt hospitals, has just been rated among the top one percent of infertility specialists nationwide. The rating procedure was conducted by Castle Connelly Medical, Ltd., is a New York City research and information company. Castle-Connelly drew candidates for the 2013 “Top Doctors” list from nominations by physicians. Then, the company’s physician-led research team analyzed several factors, including each nominee’s medical education, training, hospital appointments, and disciplinary history. Dr. McGovern is a member physician of the Continuum Reproductive Center at Roosevelt Hospital. He treats infertility with in vitro fertilization (IVF), operative laparoscopy, and operative hysteroscopy; he is also a trained robotic surgeon and performs robotic-assisted laparoscopic myomectomy.
Dr. McGovern is certified by the American Board of Obstetrics and Gynecology in reproductive endocrinology and infertility, and in obstetrics and gynecology. After graduating from the New York University School of Medicine, he completed his residency in obstetrics and gynecology at NYU-Bellevue Medical Center. He subsequently completed his fellowship in reproductive endocrinology and infertility at UMDNJ-New Jersey Medical School. He came to St. Luke’s and Roosevelt hospitals from the University of Medicine and Dentistry of New Jersey (UMDNJ)-New Jersey Medical School, where he was Professor of Obstetrics, Gynecology, and Women’s Health; Director of the Division of Reproductive Endocrinology and Infertility since 1999; and REI Fellowship Program Director.
Among many notable accomplishments, Dr. McGovern was a steering-committee member of the NIH-funded National Cooperative Multicenter Reproductive Medicine Network from 2000-2007. While in this role, he served as the network’s principal investigator at UMDNJ, leading research on polycystic ovary syndrome (PCOS) and its interaction with infertility therapy. The randomized, controlled trial evaluated pregnancy rates in 626 women with PCOS who were treated with clomiphene citrate (Clomid), metformin (Glucophage), or the combination. Published in the New England Journal of Medicine, this groundbreaking research conclusively demonstrated that clomiphene citrate was the superior therapeutic option. Additional studies performed by Dr. McGovern and the Reproductive Medicine Network revealed that home ovulation (urine-LH) testing is less reliable than believed, that body weight is a predictor of success in PCOS treatments, and that spontaneous or induced bleeding before initiation of ovulation induction in PCOS actually lowers pregnancy rates significantly.
In recent work at the New Jersey Medical School, Dr. McGovern and his colleagues showed that traditional predictors of multiple pregnancy, estrogen level and number of ultrasound-visible follicles, are not effective cancellation criteria for artificial insemination after stimulation with injectable fertility drugs (gonadotropins); that antral (fluid-filled) follicle count is a significant predictor of live-birth pregnancy in IVF treatment cycles; that singleton pregnancies after IVF treatment have a greater risk of preterm delivery than do those in the general population; and that adnexal/ovarian torsion is not associated with an increased risk of thromboembolic phenomena (blood clots), so it is safe to attempt ovarian preservation in such cases.
From 2001-2005, Dr. McGovern served as UMDNJ site co-investigator for the NIH-funded Women’s Health Initiative, which answered many questions about the role of hormone replacement therapy in postmenopausal women. In addition, he is an oral examiner for the American Board of Obstetrics and Gynecology in general obstetrics and gynecology and in the reproductive endocrinology and infertility subspecialty. He is a reviewer for the journals Fertility and Sterility, Obstetrics and Gynecology, and Journal of Clinical Endocrinology and Metabolism, and is an associate editor of Fertility and Sterility.
He serves on the Content Review Committee for the American Society for Reproductive Medicine (ASRM), and is the Clinical Director for the Society for Assisted Reproductive Technology (SART) which is responsible for oversight of all IVF centers in the USA.
“Through his endeavors in clinical research and his nationally recognized clinical expertise in reproductive endocrinology, Dr. McGovern has clearly demonstrated his leadership qualities. We are delighted to welcome him to the ranks of our clinical chairmen,” says Frank J. Cracolici, President of St. Luke’s and Roosevelt hospitals.
In his capacity as chairman, Dr. McGovern can be contacted at Roosevelt Hospital, 1000 Tenth Avenue, Suite 10C-01, New York, New York, 10019; phone 212-523-8234. For his services as an infertility specialist, contact him at the Continuum Reproductive Center, 425 West 59th Street, Suite 5A, New York, New York, 10019; phone 212-523-7751.
Robert Neuwirth, MD, Pioneer
Minimally-Invasive GYN Surgery
Robert Neuwirth, MD, chairman of the Department of Obstetrics and Gynecology from 1974-1991, passed away on Tuesday, December 17. Dr. Neuwirth had a long and active professional life, making many vital contributions to our field. He was a pioneer of minimally-invasive techniques that avoid large incisions during gynecologic surgery. Read more about Dr. Neuwirth.
Please visit the Parent/Family Education Program Page for a full listing of all our classes on how to find a physician or midwife and decide where and how to give birth. Included: preconception, choices in childbirth, Lamaze, Introduction to the Birthing Center, breastfeeding, and many more!
5th Annual Workshop on Laparoscopic, Vaginal, and Robotic Hysterectomy
With Intensive, Hands-On Laparoscopic Suturing
December 5-6, 2013
The Roosevelt Hotel
New York, NY
Minimally-Invasive Surgery in the Department of Obstetrics and Gynecology
Physician leaders from several areas of the Department of Obstetrics and Gynecology have come together to offer a wide range of minimally-invasive surgical treatments for gynecologic problems.
These new treatments are as safe and effective as their traditional counterparts requiring a major incision, and come with a host of advantages: less scarring, shorter hospital stay and recovery time, and fewer potential complications. Directing the Division of Minimally Invasive Surgery and Gynecologic Robotics is Farr Nezhat, MD, FACOG.
Dr. Nezhat is a nationally and internationally-known innovator who has developed a host of minimally-invasive techniques.
Barely-there underwear, Brazilian bikini waxes, and shaved pubic hair have become cultural beauty standards for women. And yet, the skin of a woman’s genital area is more sensitive than the skin on her face. Lisa Dabney, MD, urogynecologist in the Department of Obstetrics and Gynecology at St. Luke’s-Roosevelt Hospital Center, wants to remind women that redness and irritation from harsh grooming procedures and tight clothing are the body’s way of saying “stop torturing me.” Here are the general guidelines that Dr. Dabney hands out to her patients with pain and discomfort in the vaginal area and recurrent yeast infections. Most of the time, says Dr. Dabney, these patients don’t have some horrible infection; they just need to change their grooming habits.
Risks of Extreme
Exercise in Pregnancy
Samantha Feder, MD, faculty OB/GYN at Roosevelt, is interviewed on CBS-Channel 2 to explain the possible risks when a woman in late pregnancy runs a marathon.